Preliminary program of the ESH Satellite Symposium «Resistant Hypertension», May 24-26, 2012,

Hotel Pribaltiyskaya, St.Petersburg, Russian Federation

May 24

9.00-17.00 / Satellite Symposia of Pharmaceuticals Companies
Hall Blue
17.00-20.00 / Opening Ceremony
Evgeny Shlyakhto (Russia). Welcoming of the participants. Hypertension burden in Russian Federation.
Alberto Zanchetti (Italy). Resistance to blood pressure lowering benefits: how far can cardiovascular risk be lowered by treatment in high risk patients?
Welcoming cocktail

May 25

Hall Blue / Hall Green
9.00-11.00 / Oral session
«Pathophysiological and clinical aspects of resistant hypertension» / Oral session
«Obstructive sleep apnea and resistant hypertension»
11.00-11.30 / Coffee-break
Hall Blue
11.30-13.30 / Plenary session
«Basic aspects of resistant hypertension»
  1. Anna Dominiczak (Scotland, UK). Genomics and other “omics” as new tools in clinical hypertension.
  2. Edward G. Lakatta (USA). Can we intervene in the epidemic of predominately systolic hypertension in Western society?
  3. Peter Nilsson (Sweden). A life course approach on cardiovascular risk. Gene-environmental influences.
  4. Stephane Laurent (France). Large artery damage as a key factor of resistant hypertension.

13.30-14.30 / Lunch
Hall Blue
14.30-16.30 / Plenary session
«Novel technologies and clinical approaches in resistant hypertension»
  1. Murray Esler (Australia). Endovascular renal denervation of the kidneys: A neuroscience cure for essential hypertension?
  2. Roland Schmieder (Germany). Renal denervation program.
  3. Krzysztof Narkiewicz (Poland). OSA and resistant hypertension.
  4. Gianfranco Parati (Italy). Carotid baroreceptor stimulation as a non-pharmacologic treatment for resistant hypertension.
  5. Margus Viigimaa (Estonia). Combination therapy in treatment of resistant hypertension.

16.00-16.30 / Coffee-break
Hall Blue / Hall Green
17.00-18.30 / Oral session
«Arterial stiffness and central blood pressure» / Master class
«Renal denervation: clinical and technical aspects»
Gala-dinner in Petrodvorets

May 26

Hall Blue
9.00-11.00 / Plenary session
«Unresolved issues of resistant hypertension»
  1. Joseph I. Shapiro (USA). Is the interventional treatment of renal artery stenosis justified?
  2. Frans Leenen (Canada). CNS effects of circulating and local aldosterone in hypertension.
  3. Elena Baranova (Russia). Management of resistant hypertension in postmenopausal women.
  4. Alexei Bagrov (USA). Cardiotonic steroids and salt-sensitivity.

11.00-11.30 / Coffee-break
Hall Blue
11.30-13.30 / Plenary session
«Clinical aspects of resistant hypertension»
  1. Lars Lindholm (Sweden). Uncontrolled hypertension – can we do better?
  2. Janna Kobalava (Russia). Patient’s compliance and resistant hypertension.
  3. Alexandra Konradi (Russia). Physician’s inertia in hypertension treatment – a significant barrier for blood pressure control.
  4. Olle Melander (Sweden). Pathophysiological links between hypertension, diabetes and cardiovascular disease.
  5. Andrzej Januszewicz (Poland).Principal findings of the Polish Resistant Hypertension [RESIST-POL] Registry – implications for clinical practice.

13.30-14.30 / Lunch
14.30-18.30 / Satellite Symposiaand Working groups